• Home
  • Stock News
  • Privacy Policy
  • Email Whitelisting
No Result
View All Result
Dividend Stocks Report
No Result
View All Result
Home Stock News

Citi downgrades Merck to neutral, says drug pipeline struggles will hold stock back

by
November 29, 2021
in Stock News
0
0
SHARES
1
VIEWS
Share on FacebookShare on Twitter

Related Posts

Keystone Pipeline Restarts at Half Capacity of 300,000 Barrels a Day

Analyst Report: Exelon Corp.

Lawler: The Second Half “Bear Steepener”: Higher for Longer, a Higher R*, and A Rising Term Premium

In his first job, Sam Bankman-Fried designed a system that called Trump’s 2016 win before major news outlets — but the firm still lost $300 million on election night

Medicine pill is seen with Merck logo displayed on a screen in the background in this illustration photo taken in Poland on October 4, 2021.

NurPhoto | NurPhoto | Getty Images

Disappointing results for some major drugs has limited the upside for Merck‘s stock, according to Citi.

Next Post

Seven High Frequency Indicators for the Economy

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

email

Get the daily email about stock.

Please Enter Your Email Address:

By opting in you agree to our Privacy Policy. You also agree to receive emails from us and our affiliates. Remember that you can opt-out any time, we hate spam too!

Popular Posts
Stock News

Keystone Pipeline Restarts at Half Capacity of 300,000 Barrels a Day

by
October 4, 2023
0

Read more

Keystone Pipeline Restarts at Half Capacity of 300,000 Barrels a Day

Analyst Report: Exelon Corp.

Lawler: The Second Half “Bear Steepener”: Higher for Longer, a Higher R*, and A Rising Term Premium

In his first job, Sam Bankman-Fried designed a system that called Trump’s 2016 win before major news outlets — but the firm still lost $300 million on election night

Strikes and the Impact on the Employment Report

Economy Is ‘Definitely Weakening’: Bill Ackman Warns Of A ‘Big Threat’ For Certain Americans. Here Are His Top 3 Holdings

Load More

All rights reserved by www.dividendstocksreport.net

  • Home
  • Stock News
  • Privacy Policy
  • Email Whitelisting
No Result
View All Result
  • Home
  • Stock News
  • Privacy Policy
  • Email Whitelisting

© 2023 JNews - Premium WordPress news & magazine theme by Jegtheme.